GlassScriptPhysician profile
Angela Hafernick
NPI 1669793006
$1,537.85
in general payments reported to CMS, 2019-2025
13 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $216 · 2021: $313 · 2022: $210 · 2023: $128 · 2024: $226 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $632.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $349.69 | 2019-2023 | Dysport |
| Astrazeneca Pharmaceuticals LP | $285.81 | 2019-2025 | Breztri, Farxiga |
| Abbvie INC. | $260.45 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $246.48 | 2020-2022 | |
| Medtronic, INC. | $138.29 | 2024 | Venaseal, Abre |
| Abbott Laboratories | $69.93 | 2022-2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $39.87 | 2023 | Cologuard Collection Kit |
| Revance Therapeutics, INC. | $39.55 | 2024 | Daxxify |
| Astellas Pharma US INC | $33.18 | 2023 | Veozah |
| Novo Nordisk INC | $28.66 | 2022 | |
| Allergan, INC. | $17.11 | 2019 | |
| Lilly USA, LLC | $16.41 | 2022 | |
| Pfizer INC. | $12.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Hafernick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.